Low-density granulocytes are phenotypically altered in people with long-COVID

Danmark Nyheder Nyheder

Low-density granulocytes are phenotypically altered in people with long-COVID
Danmark Seneste Nyt,Danmark Overskrifter
  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 68 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 71%

Low-density granulocytes are phenotypically altered in people with long-COVID Coronavirus Disease COVID SARSCoV2 biorxivpreprint uhmanoa uhmed

Studies have reported elevated LDG counts in severe SARS-CoV-2 infections; however, the long-term impact of coronavirus disease 2019 on LDG expression and phenotypic alterations has not been well-characterized. Further research is required to assess the functional contributions of LDGs to pulmonary post-acute sequelae of COVID-19 development.

The study comprised 12 SARS-CoV-2 infection convalescent individuals with pulmonary symptoms and 10 recovered individuals without residual COVID-19 symptoms . For comparison, 12 human immunodeficiency virus -negative individuals from a previously conducted study were included as SARS-CoV-2-naïve controls .

Further, flow cytometry analysis and enzyme-linked immunosorbent assays were performed to compare LDG levels and their phenotypes based on markers of activation, maturation, and NET formation. In addition, LDG activation was assessed based on the myeloperoxidase and cluster of differentiation 11b expression and LDG granularity.

PPASC patient LDGs showed enhanced NET-forming capability and platelet aggregation than NRS and NP group individuals. LDGs showed CD11b+/CD14-/CD15+/CD16+/CD45+ expression. PPASC patients showed a rising trend in LDG proportion and significantly higher LDG counts than controls . The findings indicated that LDGs showed an elevated frequency of mature LDGs, and their counts persisted at high levels for several months post-COVID-19, even among recovered NRS COVID-19 patients lacking residual COVID-19 symptoms. The PPASC and NRS group individuals showed more mature LDG NPs than controls, and the CD16hi and CD16lo LDG subsets showed higher expression among PPASC patients.

Vi har opsummeret denne nyhed, så du kan læse den hurtigt. Hvis du er interesseret i nyheden, kan du læse hele teksten her. Læs mere:

NewsMedical /  🏆 19. in UK

Danmark Seneste Nyt, Danmark Overskrifter

Similar News:Du kan også læse nyheder, der ligner denne, som vi har indsamlet fra andre nyhedskilder.

Increased Gibbs energy of binding indicates greater infectivity of SARS-CoV-2 BA.2.75Increased Gibbs energy of binding indicates greater infectivity of SARS-CoV-2 BA.2.75Increased Gibbs energy of binding indicates greater infectivity of SARS-CoV-2 BA.2.75 Coronavirus Disease COVID SARSCoV2 MDPIOpenAccess TU_Muenchen
Læs mere »

Is vaccine status associated with the severity of Omicron SARS-CoV-2 infection in hospitalized patients?Is vaccine status associated with the severity of Omicron SARS-CoV-2 infection in hospitalized patients?Is vaccine status associated with the severity of Omicron SARS-CoV-2 infection in hospitalized patients? medrxivpreprint Omicron SARSCoV2 infection COVID19 coronavirus covid vaccine vaccination
Læs mere »

Vaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariantsVaccination- and/or natural infection-induced immune responses against SARS-CoV-2 Omicron subvariantsResearchers comparatively evaluated the neutralization antibody titers for SARS-CoV-2 Omicron VOC subvariants BA.1, BA.2, BA.4/5 among individuals with ancestral B.1 strain infections, vaccinated individuals, or with hybrid immunity from breakthrough infections and vaccinations with Delta or Gamma VOCs.
Læs mere »

DNA damage in older age increases expression of ACE2 and SARS-CoV-2 infection riskDNA damage in older age increases expression of ACE2 and SARS-CoV-2 infection riskDNA damage in older age increases expression of ACE2 and SARS-CoV-2 infection risk AgingCell DNA DNAdamage age infection SARSCoV2
Læs mere »

Omicron BA.4/BA.5 bivalent mRNA vaccine booster elicits similar neutralizing antibody responses to monovalent vaccineOmicron BA.4/BA.5 bivalent mRNA vaccine booster elicits similar neutralizing antibody responses to monovalent vaccineResearchers analyzed the antibody response induced by the new bivalent mRNA SARS-CoV-2 vaccines in individuals who have been fully vaccinated with monovalent vaccines and those who have had breakthrough infection with the SARS-CoV-2 Omicron BA.4/BA.5 variants.
Læs mere »

The effectiveness of BNT162b2 COVID-19 vaccine against infection with SARS-CoV-2 Omicron subvariants BA.4/5The effectiveness of BNT162b2 COVID-19 vaccine against infection with SARS-CoV-2 Omicron subvariants BA.4/5The effectiveness of BNT162b2 COVID-19 vaccine against infection with SARS-CoV-2 Omicron subvariants BA.4/5 TheLancetInfDis COVID19 coronavirus covid vaccine vaccination Omicron infection
Læs mere »



Render Time: 2025-03-23 10:08:47